4//SEC Filing
DIAZ REINALDO M 4
Accession 0001209191-22-036566
CIK 0001693011other
Filed
Jun 13, 8:00 PM ET
Accepted
Jun 14, 7:47 AM ET
Size
5.5 KB
Accession
0001209191-22-036566
Insider Transaction Report
Form 4
DIAZ REINALDO M
Director
Transactions
- Award
Stock Option (right to buy)
2022-06-10+9,367→ 9,367 totalExercise: $4.38Exp: 2032-06-09→ Common Stock (9,367 underlying)
Footnotes (1)
- [F1]The option was granted on June 10, 2022. The shares underlying the option are scheduled to vest as to 100% of the shares on June 10, 2023, or, if earlier, immediately prior to the first annual meeting of stockholders occurring after the grant date.
Documents
Issuer
Inozyme Pharma, Inc.
CIK 0001693011
Entity typeother
Related Parties
1- filerCIK 0001250086
Filing Metadata
- Form type
- 4
- Filed
- Jun 13, 8:00 PM ET
- Accepted
- Jun 14, 7:47 AM ET
- Size
- 5.5 KB